The influence of low-carbohydrate diets on the metabolic response to androgen-deprivation therapy in prostate cancer.

Prostate cancer (PC) is the second most lethal cancer for men. For metastatic PC, standard first-line treatment is androgen deprivation therapy (ADT). While effective, ADT has many metabolic side effects.